USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, personal care and skincare products sold directly to Brand Partners and Preferred Customers across 25 global markets. Company news regularly centers on earnings releases, management commentary, omnichannel strategy, product innovation and channel expansion.
Recurring updates also cover product launches and quality validation for brands such as CellSentials, Celavive and Glow, along with the company’s controlling stake in Hiya Health Products, its ownership of Rise Wellness, athlete sponsorships and USANA Foundation activity.
USANA Health Sciences, Inc. reported financial results for Q1 2024, with net sales at $228 million, a decrease from Q1 2023. Diluted EPS was $0.86 compared to $0.95 in Q1 2023. The company reiterated its fiscal year 2024 net sales and EPS outlook. Despite strong growth in China, results in other key markets fell short of expectations. The company remains focused on accelerating growth in 2024 through engagement with Associate leaders worldwide. USANA also completed its first quarter of operations in India with expectations of long-term growth.
USANA recently released its fourth annual sustainability report, showcasing its commitment to sustainability and positive business practices. The report highlights achievements such as employee engagement, gender diversity in leadership, renewable energy use, waste diversion, plastic reduction, meals provided through the USANA Foundation, and investment in research and development.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.